Advertisement Eclinso, XClinical strike partnership agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Eclinso, XClinical strike partnership agreement

Eclinso has signed a strategic partnership agreement with eClinical technology solutions company, XClinical.

Eclinso’s trialforce Platform and XClinical’s Electronic Data Capture (EDC) system, Marvin, offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CROs) for capturing and managing clinical data.

Trialforce is a cloud-based managed application platform that helps in lowering the initial licensing fees associated with EDC and Data Management solutions.

Marvin, which is built on CDISC standards, enables pharmaceutical, CROs and MedTech companies to increase clinical trial efficiency.

Marvin can be used across all types of therapeutic areas, including Phase I-IV interventional studies, medical device trials, observational studies, registry trials, prevention studies, genetic investigations, diagnostic trials, and outcomes research.

Integrated with trialforce, Marvin offers unparalleled visibility, exception management, and analysis of information from clinical trials, enabling trial sponsors and managers to make critical decisions during and throughout a trial.

Eclinso CEO Frank Pijpers said the convergence of cloud-based solutions such as Trialforce with Marvin will improve clinical trial efficiency while reducing costs.

Eclinso is a provider of clinical information technology, consulting and business process outsourcing services.